Skip to main content
VCbacked
Log inGet Started

TenNor Therapeutics

Westfield, United States

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

$42.1M raised
Oct 2024
Series E
BiotechnologyMedicalTherapeutics

Top Investors

Northern Light Venture CapitalSNÖ VenturesWuXi Healthcare VenturesOriza VenturesOriza Holdings

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TenNor Therapeutics

How much funding has TenNor Therapeutics raised?
TenNor Therapeutics has raised $42.1M in total funding. The most recent round was Series E. The last funding was announced in October 2024.
Who are TenNor Therapeutics's investors?
TenNor Therapeutics's investors include Northern Light Venture Capital, SNÖ Ventures, WuXi Healthcare Ventures, Oriza Ventures, Oriza Holdings.
Where is TenNor Therapeutics headquartered?
TenNor Therapeutics is headquartered in Westfield, United States.
What does TenNor Therapeutics do?
TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases
What stage is TenNor Therapeutics at?
TenNor Therapeutics is at the Series E stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"TenNor Therapeutics — Funding & Investors." VCBacked, October 16, 2024, https://www.vcbacked.co/company/tennor-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2024). TenNor Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/tennor-therapeutics
Wikipedia (cite web)
{{cite web |title=TenNor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tennor-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong